Literature DB >> 7103794

Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss.

J J Corbett, P J Savino, H S Thompson, T Kansu, N J Schatz, L S Orr, D Hopson.   

Abstract

The prognosis for vision in most patients with pseudotumor cerebri is excellent; however, visual loss, which is the only serious complication, may occur either early or late in the course of the disease. A group of 57 patients was followed up five to 41 years with visual fields, visual acuity, and fundus photographs. Blinding visual loss or severe visual impairment in one or both eyes occurred in 14 patients, and in seven patients, this occurred months to years after the initial symptoms. Systemic hypertension was a significant risk factor for visual loss in patients with pseudotumor cerebri, and blindness occurred in eight of 13 patients who were hypertensive. Despite suggestions that blind spot measurement is useful for following up patients with this condition, we believe that sequential quantitative perimetry gives more complete information and is essential to rational decision making in the treatment of pseudotumor cerebri.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7103794     DOI: 10.1001/archneur.1982.00510200003001

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  133 in total

1.  Infantile pseudotumor cerebri related to viral illness.

Authors:  S K Tamer; U Tamer; P Warey
Journal:  Indian J Pediatr       Date:  1996 Sep-Oct       Impact factor: 1.967

2.  Idiopathic Intracranial Hypertension.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

3.  Doxycycline induced intracranial hypertension.

Authors:  J Lochhead; J S Elston
Journal:  BMJ       Date:  2003-03-22

4.  Not so benign intracranial hypertension.

Authors:  Kathleen B Digre
Journal:  BMJ       Date:  2003-03-22

Review 5.  Pseudotumor cerebri.

Authors:  Pietro Spennato; Claudio Ruggiero; Raffaele Stefano Parlato; Maria Consiglio Buonocore; Antonio Varone; Emilio Cianciulli; Giuseppe Cinalli
Journal:  Childs Nerv Syst       Date:  2010-08-19       Impact factor: 1.475

Review 6.  [Characteristic neurological features, differential diagnostic criteria and medicinal treatment of idiopathic intracranial hypertension].

Authors:  K-D Willenborg; W Nacimiento
Journal:  Ophthalmologe       Date:  2015-10       Impact factor: 1.059

7.  Idiopathic intracranial hypertension is not benign: a long-term outcome study.

Authors:  Hanne M Yri; Marianne Wegener; Birgit Sander; Rigmor Jensen
Journal:  J Neurol       Date:  2011-10-19       Impact factor: 4.849

8.  Progressive visual deterioration leading to blindness after pediatric heart transplantation.

Authors:  K O Schowengerdt; R J Gajarski; S Denfield
Journal:  Tex Heart Inst J       Date:  1993

9.  Idiopathic Intracranial Hypertension: Diagnostic Accuracy of the Transverse Dural Venous Sinus Attenuation on CT Scans.

Authors:  Yosra Abdelzaher Ibrahim; Oleg Mironov; Ahmed Deif; Rajiv Mangla; Jeevak Almast
Journal:  Neuroradiol J       Date:  2014-12-01

10.  Baseline BMI is a strong predictor of nadir BMI after adolescent gastric bypass.

Authors:  Thomas H Inge; Todd M Jenkins; Meg Zeller; Lawrence Dolan; Stephen R Daniels; Victor F Garcia; Mary L Brandt; Judy Bean; Kimberlee Gamm; Stavra A Xanthakos
Journal:  J Pediatr       Date:  2010-01       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.